Qube Research & Technologies (QRT)
TARO

Qube Research & Technologies (QRT)’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-231,004
Closed -$9.78M – 4922
2024
Q1 		$9.78M Buy
231,004
+228,530
+9,237% +$9.63M 0.02% 861
2023
Q4 		$103K Buy
+2,474
New +$91.2K ﹤0.01% 3083
2023
Q2 		– Sell
-13,694
Closed -$333K – 3163
2023
Q1 		$333K Buy
+13,694
New +$399K ﹤0.01% 1709

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $3.3B AUM 20.27% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $2.24B AUM 23.45% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TARO Position: Q2 2024 in Review

Qube Research & Technologies (QRT) sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 231,004 shares — an estimated $9.78M sold.

Qube Research & Technologies (QRT) first reported a position in TARO in Q1 2023 and held it in 3 quarters. The position peaked at $9.78M in Q1 2024. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • Qube Research & Technologies (QRT) reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 231,004 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $9.78M.
  • Qube Research & Technologies (QRT) first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2023 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s Taro Pharmaceutical Industries Ltd. position peaked at $9.78M in Q1 2024.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.